News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
459,099 Results
Type
Article (30185)
Company Profile (193)
Press Release (428721)
Section
Business (131853)
Career Advice (609)
Deals (21838)
Drug Delivery (50)
Drug Development (56103)
Employer Resources (60)
FDA (11549)
Job Trends (9605)
News (220892)
Policy (16691)
Tag
Academia (1988)
Alliances (39279)
Alzheimer's disease (846)
Antibody-drug conjugate (ADC) (110)
Approvals (11549)
Artificial intelligence (218)
Bankruptcy (154)
Best Places to Work (8246)
Biotechnology (147)
Breast cancer (192)
Cancer (1644)
Career advice (523)
CAR-T (139)
Cell therapy (406)
Clinical research (43863)
Collaboration (615)
Compensation (161)
COVID-19 (1758)
C-suite (129)
Data (1325)
Diabetes (114)
Diagnostics (5364)
Earnings (46570)
Events (67848)
Executive appointments (411)
FDA (12263)
Funding (497)
Gene therapy (244)
GLP-1 (317)
Government (1885)
Healthcare (12482)
Infectious disease (1838)
Inflammatory bowel disease (90)
IPO (9962)
Job creations (1734)
Job search strategy (457)
Layoffs (226)
Legal (2998)
Lung cancer (269)
Lymphoma (119)
Manufacturing (181)
Medical device (11634)
Medtech (11639)
Mergers & acquisitions (12202)
Metabolic disorders (264)
Neuroscience (1130)
NextGen: Class of 2025 (4220)
Non-profit (2050)
Northern California (1437)
Obesity (117)
Opinion (113)
Patents (123)
People (37955)
Phase I (15844)
Phase II (19848)
Phase III (13213)
Pipeline (558)
Postmarket research (1064)
Preclinical (7176)
Radiopharmaceuticals (189)
Rare diseases (257)
Real estate (3832)
Regulatory (12951)
Research institute (1888)
Resumes & cover letters (97)
Series A (96)
Southern California (1341)
Startups (2848)
United States (13629)
Vaccines (407)
Date
Last 7 days (588)
Last 30 days (1886)
Last 365 days (25063)
2025 (3829)
2024 (25801)
2023 (29672)
2022 (39374)
2021 (41794)
2020 (38587)
2019 (31338)
2018 (23610)
2017 (23479)
2016 (21915)
2015 (25580)
2014 (18889)
2013 (16027)
2012 (17073)
2011 (17322)
2010 (15602)
Location
Africa (396)
Arizona (119)
Asia (29701)
Australia (5227)
California (3434)
Canada (1150)
China (316)
Colorado (162)
Connecticut (148)
Europe (62244)
Florida (494)
Georgia (121)
Illinois (301)
Indiana (161)
Japan (111)
Maryland (534)
Massachusetts (2689)
Michigan (187)
Minnesota (265)
New Jersey (993)
New York (1057)
North Carolina (621)
Northern California (1437)
Ohio (129)
Pennsylvania (792)
South America (601)
Southern California (1341)
Texas (565)
Utah (110)
Washington State (390)
459,099 Results for "stemedica cell technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
Fuse Vectors secures $5.2m to advance cell-free gene therapy technology, led by HCVC
February 26, 2025
·
7 min read
Press Releases
Shift Bioscience Establishes North American Facilities to Expand Capabilities of AI-Powered Virtual Cell Technology
February 18, 2025
·
3 min read
Press Releases
Onco-Innovations’ Licensed Technology Shows Promise in Enhancing Chemotherapy Effectiveness by Overcoming Cancer Cell Resistance and Inhibiting Cancer Cell Repair
January 30, 2025
·
7 min read
Deals
AbbVie Triples Down on T Cell Therapies in Xilio Deal Worth Up to $2.1B
The pharma giant inked its third T cell engager deal of 2025 Wednesday—this time with Xilio Therapeutics for tumor-activated immunotherapies.
February 12, 2025
·
1 min read
·
Kate Goodwin
Press Releases
Onco-Innovations’ Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study
February 10, 2025
·
7 min read
Press Releases
Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued U.S. Patent for iACT Stealth™ Technology
February 12, 2025
·
2 min read
Press Releases
Onco-Innovations’ Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells
January 17, 2025
·
5 min read
Press Releases
Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications
January 21, 2025
·
2 min read
1 of 45,910
Next
